A detailed history of Intech Investment Management LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Intech Investment Management LLC holds 29,055 shares of MYGN stock, worth $399,215. This represents 0.01% of its overall portfolio holdings.

Number of Shares
29,055
Previous 22,012 32.0%
Holding current value
$399,215
Previous $538,000 47.77%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$23.97 - $28.6 $168,820 - $201,429
7,043 Added 32.0%
29,055 $795,000
Q2 2024

Aug 12, 2024

BUY
$17.98 - $25.47 $395,775 - $560,645
22,012 New
22,012 $538,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.11B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.